Renal amyloidosis secondary prevention: Difference between revisions
Jump to navigation
Jump to search
Line 7: | Line 7: | ||
==Secondary Prevention== | ==Secondary Prevention== | ||
Treatment of the primary disease and underlying cause will provide favorable renal outcome.<ref name="pmid27942184">{{cite journal |vauthors=Hajra A, Bandyopadhyay D |title=An interesting case of renal amyloidosis |journal=Indian J Nephrol |volume=26 |issue=6 |pages=467–469 |date=2016 |pmid=27942184 |pmc=5131391 |doi=10.4103/0971-4065.177143 |url=}}</ref> | * Treatment of the primary disease and underlying cause will provide favorable renal outcome.<ref name="pmid27942184">{{cite journal |vauthors=Hajra A, Bandyopadhyay D |title=An interesting case of renal amyloidosis |journal=Indian J Nephrol |volume=26 |issue=6 |pages=467–469 |date=2016 |pmid=27942184 |pmc=5131391 |doi=10.4103/0971-4065.177143 |url=}}</ref> | ||
==References== | ==References== |
Revision as of 21:16, 21 June 2018
Renal amyloidosis Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Template:Renal amyloidosis On the Web |
American Roentgen Ray Society Images of Renal amyloidosis secondary prevention |
Risk calculators and risk factors for Renal amyloidosis secondary prevention |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Shaghayegh Habibi, M.D.[2]
Overview
Secondary Prevention
- Treatment of the primary disease and underlying cause will provide favorable renal outcome.[1]
References
- ↑ Hajra A, Bandyopadhyay D (2016). "An interesting case of renal amyloidosis". Indian J Nephrol. 26 (6): 467–469. doi:10.4103/0971-4065.177143. PMC 5131391. PMID 27942184.